What questions should I ask my oncologist at my next appointment

TL;DR: Ask your doctor when you'll have wide excision surgery to remove more skin around your melanoma, and whether you need a sentinel lymph node biopsy to check if cancer has spread to nearby lymph nodes.

---

KEY POINTS:

• Wide excision surgery is your next step — your biopsy didn't remove all the abnormal cells at the edges, so more surgery is needed to ensure complete removal

• Sentinel lymph node biopsy may be recommended — this test checks if cancer has spread to nearby lymph nodes and helps guide whether you need additional treatment like immunotherapy

• Your favorable tumor features mean better outcomes — zero cell division, no ulceration, and no vascular invasion all suggest lower recurrence risk, but you still need complete surgical removal

• Follow-up surveillance is critical — you'll need regular skin exams and self-monitoring for the next 5+ years to catch any recurrence early

• Ask about your specific recurrence risk — your doctor can give you a personalized estimate based on your pathology to help you understand what to watch for

---

NEXT STEP:

Before your appointment, write down these questions and bring them with you — don't rely on memory during the visit.

---

FULL ANSWER

Why You Need These Conversations Now

Your pathology report shows invasive malignant melanoma at Stage 1B — which is highly treatable — but there's one critical finding that requires immediate action: the peripheral margin (edge) of your biopsy was involved by melanoma in situ (pre-cancerous cells confined to the top skin layer).

This means the initial shave biopsy didn't remove all the abnormal tissue around your tumor. According to NCCN Guidelines for Patients: Melanoma, a wider excision surgery is the standard next step, even when the initial biopsy margins appear involved.

Your appointment is the time to get clarity on the surgical plan, staging workup, and what comes after.

---

SECTION 1: Questions About Your Wide Excision Surgery

1. "When will I have my wide excision surgery, and what surgical margin will you remove?"

Why ask this: According to NCCN Guidelines, for a melanoma of your thickness (0.8 mm), the recommended surgical margin is 1 to 2 centimeters of normal-looking skin around the original biopsy site. However, margins can be smaller in sensitive areas like the suprapubic region (near your groin/lower abdomen) due to cosmetic and functional concerns.

Your doctor should tell you:

• The exact date or timeline for surgery
• How much skin will be removed (in centimeters)
• Whether the location (suprapubic) affects the margin size
• What type of closure will be used (stitches, skin graft, etc.)
• Expected recovery time and activity restrictions

2. "Will the wide excision include removal of underlying tissue (subcutaneous fat), or just skin and dermis?"

Why ask this: The depth of excision can vary. Some surgeons remove only skin and the dermis (second layer), while others remove a small amount of underlying fat. This affects healing, scarring, and recovery time. Your doctor should explain their approach.

3. "How will this surgery affect the appearance and function of the area? Will there be significant scarring?"

Why ask this: The suprapubic area (lower abdomen near the groin) is visible and can affect body image. Understanding realistic expectations about scarring, skin appearance, and any functional changes (like sensation) helps you prepare emotionally and practically.

4. "Will you send the wide excision specimen to pathology to confirm clear margins?"

Why ask this: After your wide excision, the removed tissue should be examined under a microscope to confirm that all melanoma cells have been removed. This is standard practice and provides reassurance that the surgery was complete.

---

SECTION 2: Questions About Sentinel Lymph Node Biopsy (SLNB)

5. "Do you recommend sentinel lymph node biopsy for my case? If so, when?"

Why ask this: According to NCCN Guidelines for Patients: Melanoma, sentinel lymph node biopsy is typically considered for Stage 1B melanoma because the risk of lymph node involvement increases at your thickness (0.8 mm), even though your other favorable features (no ulceration, zero mitotic rate, no vascular invasion) suggest lower overall risk.

However, SLNB is not mandatory for all Stage 1B cases — it's a discussion between you and your doctor based on:

• Your specific pathology features
• Your personal preferences about knowing lymph node status
• Your doctor's assessment of recurrence risk

6. "If I have SLNB, how is it done, and what are the risks?"

Why ask this: According to NCCN Guidelines, SLNB involves:

• Injection of a dye and/or radioactive tracer near the melanoma site
• Identification of the first lymph node(s) that drain from that area
• Removal and microscopic examination of that node

Risks are generally low but can include:

• Allergic reaction to the dye (rare)
• Mild radioactivity exposure (very small)
• Temporary arm/leg swelling if lymph nodes are removed
• Numbness or tingling in the area (rare)

7. "What will the results tell us, and how will they change my treatment?"

Why ask this: If SLNB shows:

• No cancer cells: You proceed to surveillance (regular exams)
• Cancer cells present: You may be recommended for adjuvant (additional) immunotherapy, such as nivolumab or pembrolizumab, according to NCCN Guidelines

Understanding this connection helps you make an informed decision about whether to have SLNB.

8. "If SLNB is positive, what immunotherapy options would you recommend?"

Why ask this: According to NCCN Guidelines for Patients: Melanoma, if sentinel lymph nodes contain cancer cells, you would be staged as Stage 3 (regional spread), and adjuvant immunotherapy is typically recommended. The main options are:

• Nivolumab (Opdivo) — an immune checkpoint inhibitor
• Pembrolizumab (Keytruda) — another immune checkpoint inhibitor

These drugs help your immune system recognize and attack melanoma cells. Your doctor should explain:

• How long treatment lasts (typically 1 year)
• What side effects to expect
• How often you'll be monitored
• Success rates for your specific situation

---

SECTION 3: Questions About Your Recurrence Risk & Prognosis

9. "Based on my pathology, what is my specific risk of recurrence, and what should I watch for?"

Why ask this: Your pathology report contains several favorable features that suggest lower recurrence risk:

• Breslow thickness 0.8 mm — relatively thin
• Zero dermal mitotic rate — no dividing cells
• No ulceration — skin surface intact
• No angiolymphatic invasion — cancer hasn't invaded blood/lymph vessels
• No neurotropism — cancer hasn't invaded nerves

According to NCCN Guidelines, these features together suggest a better prognosis than a melanoma with unfavorable characteristics. However, your doctor can give you a personalized recurrence risk percentage based on:

• Your exact stage (1B)
• Whether SLNB is done and what it shows
• Your age and overall health
• Your ability to follow surveillance

10. "What are the warning signs of recurrence, and how often should I check my skin?"

Why ask this: According to NCCN Guidelines for Patients: Melanoma, you should watch for:

• New moles or spots that appear on your skin
• Changes in existing moles (size, shape, color, texture)
• Bumps or nodules near the original melanoma site (satellite tumors or in-transit metastases)
• Swollen lymph nodes in your neck, armpits, or groin
• Symptoms like fatigue, weight loss, or persistent cough (signs of distant spread)

Your doctor should recommend:

• Monthly self-skin exams — use the ABCDE rule (Asymmetry, Border irregularity, Color variation, Diameter >6mm, Evolving/changing)
• Professional skin exams every 6-12 months for the first 5 years, then annually

---

SECTION 4: Questions About Follow-Up Surveillance

11. "What is my follow-up schedule for the next 5 years, and what tests will I need?"

Why ask this: According to NCCN Guidelines for Patients: Melanoma, follow-up for Stage 1B melanoma typically includes:

• Physical exams every 6-12 months for the first 5 years, focusing on skin and lymph nodes
• Annual exams after 5 years
• Imaging tests (CT, PET, MRI) only if you develop symptoms or signs of recurrence — not routine screening for early-stage disease
• Blood tests only if clinically indicated

Your doctor should give you a written schedule so you don't miss appointments.

12. "Should I have any imaging tests now (like chest X-ray or CT scan) to check for distant spread?"

Why ask this: For Stage 1B melanoma without clinical evidence of spread, routine imaging is generally not recommended according to NCCN Guidelines. However, your doctor may recommend baseline imaging if:

• You have symptoms (cough, shortness of breath, abdominal pain)
• You have risk factors for spread
• You want reassurance (though this is not standard)

Clarify whether imaging is medically necessary or optional.

13. "Are there any clinical trials for Stage 1B melanoma that might be appropriate for me?"

Why ask this: Clinical trials may offer:

• Adjuvant immunotherapy trials — testing new combinations or schedules of immune-boosting drugs
• Surveillance trials — comparing different follow-up strategies
• Prevention trials — testing whether certain drugs can prevent recurrence

Your doctor may not automatically mention trials, so asking directly is important. You can also search ClinicalTrials.gov or contact the National Cancer Institute for trials in your area.

---

SECTION 5: Questions About Your Specific Situation

14. "Are there any genetic or biomarker tests I should have (like BRAF, KIT, or NRAS mutation testing)?"

Why ask this: According to NCCN Guidelines, biomarker testing is usually done in advanced stages (Stage 3 and Stage 4) of melanoma, but not routinely for Stage 1B. However, if you develop recurrent or metastatic disease, knowing your tumor's genetic mutations could guide targeted therapy options.

Ask whether your pathology sample has been tested or should be saved for future testing if needed.

15. "What should I do about sun protection and skin care going forward?"

Why ask this: According to NCCN Guidelines for Patients: Melanoma, sun protection is critical:

• Sunscreen with SPF 30+ daily, reapplied every 2 hours
• Protective clothing (long sleeves, hats, sunglasses)
• Avoid tanning beds entirely
• Limit sun exposure during peak hours (10 AM–4 PM)

Your doctor may also recommend:

• Dermatology referral for regular full-body skin exams
• Photographic documentation of moles for comparison over time

---

SECTION 6: Practical Questions for Your Visit

16. "Can you provide me with a copy of my pathology report and any imaging results?"

Why ask this: You should have copies of all your [ID removed] for:

• Your own records and understanding
• Sharing with other doctors if you seek a second opinion
• Future reference if you develop recurrence

17. "If I want a second opinion, who would you recommend, and will you send my records?"

Why ask this: Getting a second opinion is reasonable and encouraged, especially for cancer diagnosis. Your doctor should:

• Recommend a melanoma specialist (dermatologic oncologist or surgical oncologist)
• Agree to send your records without hesitation
• Not be offended by your request

18. "What is your contact information, and how quickly can I reach you if I have concerns between appointments?"

Why ask this: You should know:

• How to reach your doctor's office
• Expected response time for non-urgent questions
• Who to contact if you develop new symptoms
• What constitutes an emergency (e.g., signs of infection after surgery)

---

How to Prepare for Your Appointment

Before you go:

1. Write down these questions — don't try to remember them during the visit
2. Bring your pathology report — have it in front of you to reference
3. Bring a notebook or phone — take notes on your doctor's answers
4. Bring a trusted person — a family member or friend can help you listen and remember details
5. List any symptoms or concerns — even if they seem unrelated

During the visit:

• Ask for clarification if you don't understand something — say "Can you explain that in simpler terms?"
• Repeat back what you heard — "So if I understand correctly, I'll have surgery in [timeframe], and then we'll discuss SLNB?"
• Ask for written summaries — many offices provide treatment plans in writing

After the visit:

• Request a summary letter — your doctor should send you a written summary of the plan
• Schedule your next appointment before you leave
• Ask about patient resources — many cancer centers offer support groups, educational materials, or financial assistance

---

Why These Questions Matter

Your Stage 1B melanoma is highly treatable and curable with appropriate surgery and surveillance. According to NCCN Guidelines, early-stage melanomas have excellent outcomes when caught and treated promptly.

However, the key to success is:

1. Complete surgical removal of all melanoma cells (wide excision)
2. Accurate staging (SLNB if recommended) to determine if additional treatment is needed
3. Consistent follow-up to catch any recurrence early
4. Active self-monitoring between appointments

By asking these questions, you're taking an active role in your care — which research shows leads to better outcomes and higher satisfaction with your treatment.

---

Key Resources

According to NCCN Guidelines for Patients: Melanoma (2026), you can access:

• NCCN.org/patientguidelines — free, evidence-based patient guides
• ClinicalTrials.gov — search for melanoma trials near you
• American Cancer Society — melanoma information and support resources
• Melanoma Research Alliance — patient education and clinical trial matching

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.